AVDL vs EQR · rev $169.1M vs P/E 26, $26.37B cap
Avadel Pharmaceuticals PLC (AVDL) versus Equity Residential (EQR) — a side-by-side from cached financials, not a winner call.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Equity Residential (EQR) is a reit - residential company listed on US.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
EQR does not have a complete income-statement cache yet.
AVDL currently screens at market cap $968.5M. EQR currently screens at market cap $26.37B and trailing P/E 25.7.
Not investment advice. Open the AVDL and EQR stock pages for the full models.
Not investment advice.